12-Month Evolution of Edge-to-Edge Repair with PASCAL

Mitral regurgitation (MR) is the most frequent valve disease. Mitral transcatheter edge-to-edge repair (M-TEER) has been shown beneficial in high or prohibitive risk patients in cases of degenerative and functional MR.  

Resultados alentadores en la válvula mitral percutánea en los pacientes complejos

The PASCAL device has been shown safe and effective by the CLASP II, but we still need further research in clinical “real world” environments. 

The MiCLASP, a prospective multicenter post-market study, included 544 patients, 322 with functional MR and 163 with degenerative MR, all with “real world” challenging anatomies.  

The safety primary outcome at 30 days was major adverse events (MAE), a composite of cardiovascular mortality, stroke, MI, reintervention, major vascular complication, major structural complication, device embolization, dialysis, and severe bleeding (defined as major, intense, life-threatening or fatal) according to VARC criteria. 

The primary efficacy outcome was MR severity vs. prior procedural MR, quality of life, 6-minute walk capacity and functional class at 30 days, 6 and 12 months. 

Read also: LpA: 30-Year Cardiovascular Followup in Primary Prevention Cohorts.

Mean patient age was 77, and 59% were men. Half of patients had been hospitalized for cardiac failure (CF) in the last year, and were most in functional class III-IV. STS score was 5.1% and EuroSCORE II was 7.1%. 81% of patients were hypertensive, 54% diabetic, 64% had atrial fibrillation, 20% had had MI, 62% pulmonary hypertension, 54% kidney function deterioration, and 27% cardiomyopathy.

The effective regurgitant orifice area was 0.35 cm2, regurgitant volume 52 ml, and vena contracta 5.9.

Implantation success rate was 97%, device success rate 94%, mean procedural time 84 minutes, and hospital stay 3.5 days.

Read also: Single Antiplatelet Therapy Following Percutaneous Left Atrial Appendage Occlusion.

30-day safety outcome resulted in 6.8%, with cardiovascular mortality 1.1%, stroke 0.9%, MI 0.2%, reintervention 1.3%, major structural complication 0.4%, device embolization 0.2%, dialysis 1.1%, severe bleeding 4% and major vascular complication 1.1%.

At 12 months, efficacy primary outcome resulted 16.4%, with no significant difference between the groups. Survival was 87.3% and freedom from rehospitalization for cardiac failure 84%, with significant reduction vs. the previous year. Also, there was sustained reduction of MR (98% ≤2+ and 83% ≤1+), improved functional class, quality of life and significant increase in 6-minute walking distance. 

Conclusion

The one year followup of this large cohort of MiCLASP patients has shown continued safety and effectiveness of edge-to-edge repair with PASCAL in this post-market analysis. Results have shown high survival, reduced hospitalization for CF, sustained reduction of MR, and improved symptoms, functional class and quality of life. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Mitral Valve Transcatheter Edge-to-Edge Repair.  1-Year Outcomes From the MiCLASP Study.

Reference: Philipp Lurz, et al. J Am Coll Cardiol Intv 2024;17:890–903.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...